Medical Dialogues presents a rare disease series, delving into the realm of uncommon medical conditions. Rare diseases are ...
Adults have more prominent risk factors like hypertension, smoking, diabetes, and age, especially after 55. In the case of ...
The study demonstrates that activating the vitamin D receptor (VDR) with calcitriol suppresses cell proliferation in ...
Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 – ...
The Australian Cardiovascular Alliance (ACvA) has received vital Federal funding to advance its innovative national approach addressing cardiovascular ...
This association does not mean constipation causes heart disease, and researchers found shared ... the occurrence of major ...
Hypertension, a consistently high blood pressure level, is a known risk factor for heart disease and stroke—both leading ...
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...
Revenue: Total revenue was $2.1 million for the quarter ended September 30, 2024, comprised of $0.6 million in net product ...
Congressman-elect Shomari Figures says his No. 1 priority is Medicaid expansion in Alabama. "If Medicaid was expanded, all ...
Soquelitinib Atopic Dermatitis Phase 1 Clinical Trial Enrolling Patients in Second Dosing CohortInterim Data from Atopic Dermatitis Trial ...